1 Cholera Vaccines Oral Live Market Overview 1.1 Product Overview and Scope of Cholera Vaccines Oral Live 1.2 Cholera Vaccines Oral Live Segment by Type 1.2.1 Global Cholera Vaccines Oral Live Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Dukoral 1.2.3 Shanchol 1.2.4 Vaxchora 1.2.5 Others 1.3 Cholera Vaccines Oral Live Segment by Application 1.3.1 Global Cholera Vaccines Oral Live Sales Comparison by Application: (2021-2027) 1.3.2 Hospital 1.3.3 Scientific Research 1.3.4 Others 1.4 Global Cholera Vaccines Oral Live Market Size Estimates and Forecasts 1.4.1 Global Cholera Vaccines Oral Live Revenue 2016-2027 1.4.2 Global Cholera Vaccines Oral Live Sales 2016-2027 1.4.3 Cholera Vaccines Oral Live Market Size by Region: 2016 Versus 2021 Versus 2027 2 Cholera Vaccines Oral Live Market Competition by Manufacturers 2.1 Global Cholera Vaccines Oral Live Sales Market Share by Manufacturers (2016-2021) 2.2 Global Cholera Vaccines Oral Live Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Cholera Vaccines Oral Live Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Cholera Vaccines Oral Live Manufacturing Sites, Area Served, Product Type 2.5 Cholera Vaccines Oral Live Market Competitive Situation and Trends 2.5.1 Cholera Vaccines Oral Live Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Cholera Vaccines Oral Live Players Market Share by Revenue 2.5.3 Global Cholera Vaccines Oral Live Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Cholera Vaccines Oral Live Retrospective Market Scenario by Region 3.1 Global Cholera Vaccines Oral Live Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Cholera Vaccines Oral Live Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Cholera Vaccines Oral Live Market Facts & Figures by Country 3.3.1 North America Cholera Vaccines Oral Live Sales by Country 3.3.2 North America Cholera Vaccines Oral Live Revenue by Country 3.3.3 the United States 3.3.4 Canada 3.4 Europe Cholera Vaccines Oral Live Market Facts & Figures by Country 3.4.1 Europe Cholera Vaccines Oral Live Sales by Country 3.4.2 Europe Cholera Vaccines Oral Live Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 UK 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Cholera Vaccines Oral Live Market Facts & Figures by Region 3.5.1 Asia Pacific Cholera Vaccines Oral Live Sales by Region 3.5.2 Asia Pacific Cholera Vaccines Oral Live Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Cholera Vaccines Oral Live Market Facts & Figures by Country 3.6.1 Latin America Cholera Vaccines Oral Live Sales by Country 3.6.2 Latin America Cholera Vaccines Oral Live Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Cholera Vaccines Oral Live Market Facts & Figures by Country 3.7.1 Middle East and Africa Cholera Vaccines Oral Live Sales by Country 3.7.2 Middle East and Africa Cholera Vaccines Oral Live Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Cholera Vaccines Oral Live Historic Market Analysis by Type 4.1 Global Cholera Vaccines Oral Live Sales Market Share by Type (2016-2021) 4.2 Global Cholera Vaccines Oral Live Revenue Market Share by Type (2016-2021) 4.3 Global Cholera Vaccines Oral Live Price by Type (2016-2021) 5 Global Cholera Vaccines Oral Live Historic Market Analysis by Application 5.1 Global Cholera Vaccines Oral Live Sales Market Share by Application (2016-2021) 5.2 Global Cholera Vaccines Oral Live Revenue Market Share by Application (2016-2021) 5.3 Global Cholera Vaccines Oral Live Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Valneva 6.1.1 Valneva Corporation Information 6.1.2 Valneva Description and Business Overview 6.1.3 Valneva Cholera Vaccines Oral Live Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Valneva Cholera Vaccines Oral Live Product Portfolio 6.1.5 Valneva Recent Developments/Updates 6.2 PaxVax 6.2.1 PaxVax Corporation Information 6.2.2 PaxVax Description and Business Overview 6.2.3 PaxVax Cholera Vaccines Oral Live Sales, Revenue and Gross Margin (2016-2021) 6.2.4 PaxVax Cholera Vaccines Oral Live Product Portfolio 6.2.5 PaxVax Recent Developments/Updates 6.3 Shantha Biotechnics Limited 6.3.1 Shantha Biotechnics Limited Corporation Information 6.3.2 Shantha Biotechnics Limited Description and Business Overview 6.3.3 Shantha Biotechnics Limited Cholera Vaccines Oral Live Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Shantha Biotechnics Limited Cholera Vaccines Oral Live Product Portfolio 6.3.5 Shantha Biotechnics Limited Recent Developments/Updates 6.4 Celldex Therapeutics 6.4.1 Celldex Therapeutics Corporation Information 6.4.2 Celldex Therapeutics Description and Business Overview 6.4.3 Celldex Therapeutics Cholera Vaccines Oral Live Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Celldex Therapeutics Cholera Vaccines Oral Live Product Portfolio 6.4.5 Celldex Therapeutics Recent Developments/Updates 6.5 Merck 6.5.1 Merck Corporation Information 6.5.2 Merck Description and Business Overview 6.5.3 Merck Cholera Vaccines Oral Live Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Merck Cholera Vaccines Oral Live Product Portfolio 6.5.5 Merck Recent Developments/Updates 6.6 Ceva Asia 6.6.1 Ceva Asia Corporation Information 6.6.2 Ceva Asia Description and Business Overview 6.6.3 Ceva Asia Cholera Vaccines Oral Live Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Ceva Asia Cholera Vaccines Oral Live Product Portfolio 6.6.5 Ceva Asia Recent Developments/Updates 7 Cholera Vaccines Oral Live Manufacturing Cost Analysis 7.1 Cholera Vaccines Oral Live Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Cholera Vaccines Oral Live 7.4 Cholera Vaccines Oral Live Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Cholera Vaccines Oral Live Distributors List 8.3 Cholera Vaccines Oral Live Customers 9 Cholera Vaccines Oral Live Market Dynamics 9.1 Cholera Vaccines Oral Live Industry Trends 9.2 Cholera Vaccines Oral Live Growth Drivers 9.3 Cholera Vaccines Oral Live Market Challenges 9.4 Cholera Vaccines Oral Live Market Restraints 10 Global Market Forecast 10.1 Cholera Vaccines Oral Live Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Cholera Vaccines Oral Live by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Cholera Vaccines Oral Live by Type (2022-2027) 10.2 Cholera Vaccines Oral Live Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Cholera Vaccines Oral Live by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Cholera Vaccines Oral Live by Application (2022-2027) 10.3 Cholera Vaccines Oral Live Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Cholera Vaccines Oral Live by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Cholera Vaccines Oral Live by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Cholera Vaccines Oral Live Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Cholera Vaccines Oral Live Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Cholera Vaccines Oral Live Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Cholera Vaccines Oral Live Covered in This Study Table 5. Global Cholera Vaccines Oral Live Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Cholera Vaccines Oral Live Sales Market Share by Manufacturers (2016-2021) Table 7. Global Cholera Vaccines Oral Live Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Cholera Vaccines Oral Live Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Cholera Vaccines Oral Live Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Cholera Vaccines Oral Live Manufacturing Sites and Area Served Table 11. Manufacturers Cholera Vaccines Oral Live Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Cholera Vaccines Oral Live by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cholera Vaccines Oral Live as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Cholera Vaccines Oral Live Sales by Region (2016-2021) & (K Units) Table 16. Global Cholera Vaccines Oral Live Sales Market Share by Region (2016-2021) Table 17. Global Cholera Vaccines Oral Live Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Cholera Vaccines Oral Live Sales by Country (2016-2021) & (K Units) Table 19. North America Cholera Vaccines Oral Live Sales Market Share by Country (2016-2021) Table 20. North America Cholera Vaccines Oral Live Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Cholera Vaccines Oral Live Revenue Market Share by Country (2016-2021) Table 22. Europe Cholera Vaccines Oral Live Sales by Country (2016-2021) & (K Units) Table 23. Europe Cholera Vaccines Oral Live Sales Market Share by Country (2016-2021) Table 24. Europe Cholera Vaccines Oral Live Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Cholera Vaccines Oral Live Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Cholera Vaccines Oral Live Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Cholera Vaccines Oral Live Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Cholera Vaccines Oral Live Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Cholera Vaccines Oral Live Revenue Market Share by Region (2016-2021) Table 30. Latin America Cholera Vaccines Oral Live Sales by Country (2016-2021) & (K Units) Table 31. Latin America Cholera Vaccines Oral Live Sales Market Share by Country (2016-2021) Table 32. Latin America Cholera Vaccines Oral Live Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Cholera Vaccines Oral Live Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Cholera Vaccines Oral Live Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Cholera Vaccines Oral Live Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Cholera Vaccines Oral Live Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Cholera Vaccines Oral Live Revenue Market Share by Country (2016-2021) Table 38. Global Cholera Vaccines Oral Live Sales (K Units) by Type (2016-2021) Table 39. Global Cholera Vaccines Oral Live Sales Market Share by Type (2016-2021) Table 40. Global Cholera Vaccines Oral Live Revenue (Million US$) by Type (2016-2021) Table 41. Global Cholera Vaccines Oral Live Revenue Share by Type (2016-2021) Table 42. Global Cholera Vaccines Oral Live Price (USD/Unit) by Type (2016-2021) Table 43. Global Cholera Vaccines Oral Live Sales (K Units) by Application (2016-2021) Table 44. Global Cholera Vaccines Oral Live Sales Market Share by Application (2016-2021) Table 45. Global Cholera Vaccines Oral Live Revenue (Million US$) by Application (2016-2021) Table 46. Global Cholera Vaccines Oral Live Revenue Share by Application (2016-2021) Table 47. Global Cholera Vaccines Oral Live Price (USD/Unit) by Application (2016-2021) Table 48. Valneva Corporation Information Table 49. Valneva Description and Business Overview Table 50. Valneva Cholera Vaccines Oral Live Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Valneva Cholera Vaccines Oral Live Product Table 52. Valneva Recent Developments/Updates Table 53. PaxVax Corporation Information Table 54. PaxVax Description and Business Overview Table 55. PaxVax Cholera Vaccines Oral Live Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. PaxVax Cholera Vaccines Oral Live Product Table 57. PaxVax Recent Developments/Updates Table 58. Shantha Biotechnics Limited Corporation Information Table 59. Shantha Biotechnics Limited Description and Business Overview Table 60. Shantha Biotechnics Limited Cholera Vaccines Oral Live Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Shantha Biotechnics Limited Cholera Vaccines Oral Live Product Table 62. Shantha Biotechnics Limited Recent Developments/Updates Table 63. Celldex Therapeutics Corporation Information Table 64. Celldex Therapeutics Description and Business Overview Table 65. Celldex Therapeutics Cholera Vaccines Oral Live Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Celldex Therapeutics Cholera Vaccines Oral Live Product Table 67. Celldex Therapeutics Recent Developments/Updates Table 68. Merck Corporation Information Table 69. Merck Description and Business Overview Table 70. Merck Cholera Vaccines Oral Live Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Merck Cholera Vaccines Oral Live Product Table 72. Merck Recent Developments/Updates Table 73. Ceva Asia Corporation Information Table 74. Ceva Asia Description and Business Overview Table 75. Ceva Asia Cholera Vaccines Oral Live Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Ceva Asia Cholera Vaccines Oral Live Product Table 77. Ceva Asia Recent Developments/Updates Table 78. Production Base and Market Concentration Rate of Raw Material Table 79. Key Suppliers of Raw Materials Table 80. Cholera Vaccines Oral Live Distributors List Table 81. Cholera Vaccines Oral Live Customers List Table 82. Cholera Vaccines Oral Live Market Trends Table 83. Cholera Vaccines Oral Live Growth Drivers Table 84. Cholera Vaccines Oral Live Market Challenges Table 85. Cholera Vaccines Oral Live Market Restraints Table 86. Global Cholera Vaccines Oral Live Sales Forecast by Type (2022-2027) & (K Units) Table 87. Global Cholera Vaccines Oral Live Sales Market Share Forecast by Type (2022-2027) Table 88. Global Cholera Vaccines Oral Live Revenue Forecast by Type (2022-2027) & (US$ Million) Table 89. Global Cholera Vaccines Oral Live Revenue Market Share Forecast by Type (2022-2027) Table 90. Global Cholera Vaccines Oral Live Sales Forecast by Application (2022-2027) & (K Units) Table 91. Global Cholera Vaccines Oral Live Sales Market Share Forecast by Application (2022-2027) Table 92. Global Cholera Vaccines Oral Live Revenue Forecast by Application (2022-2027) & (US$ Million) Table 93. Global Cholera Vaccines Oral Live Revenue Market Share Forecast by Application (2022-2027) Table 94. Global Cholera Vaccines Oral Live Sales Forecast by Region (2022-2027) & (K Units) Table 95. Global Cholera Vaccines Oral Live Sales Market Share Forecast by Region (2022-2027) Table 96. Global Cholera Vaccines Oral Live Revenue Forecast by Region (2022-2027) & (US$ Million) Table 97. Global Cholera Vaccines Oral Live Revenue Market Share Forecast by Region (2022-2027) Table 98. Research Programs/Design for This Report Table 99. Key Data Information from Secondary Sources Table 100. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Cholera Vaccines Oral Live Figure 2. Global Cholera Vaccines Oral Live Market Share by Type in 2020 & 2027 Figure 3. Dukoral Product Picture Figure 4. Shanchol Product Picture Figure 5. Vaxchora Product Picture Figure 6. Others Product Picture Figure 7. Global Cholera Vaccines Oral Live Market Share by Application in 2020 & 2027 Figure 8. Hospital Figure 9. Scientific Research Figure 10. Others Figure 11. Global Cholera Vaccines Oral Live Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Cholera Vaccines Oral Live Market Size 2016-2027 (US$ Million) Figure 13. Global Cholera Vaccines Oral Live Sales 2016-2027 (K Units) Figure 14. Global Cholera Vaccines Oral Live Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 15. Cholera Vaccines Oral Live Sales Share by Manufacturers in 2020 Figure 16. Global Cholera Vaccines Oral Live Revenue Share by Manufacturers in 2020 Figure 17. The Global 5 and 10 Largest Cholera Vaccines Oral Live Players: Market Share by Revenue in 2020 Figure 18. Cholera Vaccines Oral Live Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 19. Global Cholera Vaccines Oral Live Sales Market Share by Region (2016-2021) Figure 20. Global Cholera Vaccines Oral Live Sales Market Share by Region in 2020 Figure 21. Global Cholera Vaccines Oral Live Revenue Market Share by Region (2016-2021) Figure 22. Global Cholera Vaccines Oral Live Revenue Market Share by Region in 2020 Figure 23. the United States Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Canada Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Germany Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. France Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. UK Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Italy Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Russia Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. China Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Japan Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. South Korea Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. India Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Australia Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. China Taiwan Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Indonesia Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Thailand Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Malaysia Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. UAE Cholera Vaccines Oral Live Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Cholera Vaccines Oral Live by Type (2016-2021) Figure 46. Sales Market Share of Cholera Vaccines Oral Live by Application (2016-2021) Figure 47. Sales Market Share of Cholera Vaccines Oral Live by Application in 2020 Figure 48. Revenue Share of Cholera Vaccines Oral Live by Application (2016-2021) Figure 49. Revenue Share of Cholera Vaccines Oral Live by Application in 2020 Figure 50. Manufacturing Cost Structure of Cholera Vaccines Oral Live Figure 51. Manufacturing Process Analysis of Cholera Vaccines Oral Live Figure 52. Cholera Vaccines Oral Live Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Valneva PaxVax Shantha Biotechnics Limited Celldex Therapeutics Merck Ceva Asia